ES2179520T3 - Utilizaciones farmaceuticas del cipres. - Google Patents

Utilizaciones farmaceuticas del cipres.

Info

Publication number
ES2179520T3
ES2179520T3 ES98933828T ES98933828T ES2179520T3 ES 2179520 T3 ES2179520 T3 ES 2179520T3 ES 98933828 T ES98933828 T ES 98933828T ES 98933828 T ES98933828 T ES 98933828T ES 2179520 T3 ES2179520 T3 ES 2179520T3
Authority
ES
Spain
Prior art keywords
prevention
well
hypercholesterolemia
cholesterol
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98933828T
Other languages
English (en)
Inventor
Nikolaos Zografos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zografos Dietetic Products S A
Original Assignee
Zografos Dietetic Products S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zografos Dietetic Products S A filed Critical Zografos Dietetic Products S A
Application granted granted Critical
Publication of ES2179520T3 publication Critical patent/ES2179520T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)

Abstract

Se ha preparado un extracto alcohólico de los frutos de Cypraesus sempervivens para utilizarlo para la prevención y el tratamiento de los trastornos metabólicos asociados al colesterol, los triglicéridos y los lípidos de manera general, en el hombre y el animal. Otros tipos de extractos, así como sus principios activos, aislados por análisis de diferentes partes del ciprés y otros coníferos cercanos son eficaces en la prevención y el tratamiento de todos los tipos de hipercolesterolemia y de perturbaciones lipídicas. La administración de una asociación de las fracciones y de las sustancias anteriores (de origen sintético o natural) ha conllevado una reducción significativo del nivel de colesterol y de LDL, así como lesiones ateromatosas. Las sustancias que forman parte de los grupos anteriores, las mezclas de dichas sustancias así como sus sales y sus ésteres, de origen sintético o natural, administrados por diferentes vías, pueden tener una acción preventiva o terapéutica en diversos tipos de hipercolesterolemia y de ateroma, en el hombre y el animal.
ES98933828T 1997-07-24 1998-07-24 Utilizaciones farmaceuticas del cipres. Expired - Lifetime ES2179520T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR97100293 1997-07-24
GR98100141 1998-04-22

Publications (1)

Publication Number Publication Date
ES2179520T3 true ES2179520T3 (es) 2003-01-16

Family

ID=26316680

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98933828T Expired - Lifetime ES2179520T3 (es) 1997-07-24 1998-07-24 Utilizaciones farmaceuticas del cipres.

Country Status (8)

Country Link
EP (1) EP0998296B1 (es)
AT (1) ATE220325T1 (es)
AU (1) AU8352098A (es)
DE (1) DE69806483T2 (es)
DK (1) DK0998296T3 (es)
ES (1) ES2179520T3 (es)
PT (1) PT998296E (es)
WO (1) WO1999007398A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100905419B1 (ko) * 2008-09-11 2009-07-02 연세대학교 산학협력단 세스퀴테르펜 유도체의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1834M (fr) * 1961-10-09 1963-05-27 Kegan Sarkisian Produits et compositions provenant du traitement des strobiles de gymnospermes.
FR2184550A1 (en) * 1972-05-17 1973-12-28 Biolog Appliq Ee Sarl Leucoanthocyanin extract of fresh cypress cones - with capillary protective activity
CA2057023A1 (fr) * 1989-05-12 1990-11-13 Leon Cariel Composition a base de proanthocyanidols, leur application pharmacologique

Also Published As

Publication number Publication date
DK0998296T3 (da) 2002-09-30
EP0998296A1 (en) 2000-05-10
DE69806483T2 (de) 2003-02-20
DE69806483D1 (de) 2002-08-14
WO1999007398A1 (en) 1999-02-18
PT998296E (pt) 2002-11-29
AU8352098A (en) 1999-03-01
ATE220325T1 (de) 2002-07-15
EP0998296B1 (en) 2002-07-10

Similar Documents

Publication Publication Date Title
EA199900468A1 (ru) Косметический препарат для очищения и ухода за кожей, содержащий экстракты растений и водоросли
BR0114712A (pt) Filtro de cigarro com efeito de retenção em radicais livres em fumaça de cigarro e seu método de preparação
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
ATE212351T1 (de) Androsten-derivate
BR9507846A (pt) Composição farmacéutica estável e fortemente concentrada de principio ativo da classe dos taxóides escolhido entre o docetaxol ou os derivados do docetaxol processo de preparação desta composição e utilização de uma solução congelada ou liofilizada
KR20210018893A (ko) 덴드로비움 노빌을 함유하는 조성물 및 그의 사용 방법
DK284386A (da) Farmaceutisk praeparat mod hudlidelser
ES2086274T1 (es) Preparado de especies de crataegus, medicamentos y su empleo para impedir la muerte cardiaca subita asi como lesiones cardiovasculares provocadas por reperfusion.
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
ES2179520T3 (es) Utilizaciones farmaceuticas del cipres.
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
EP1429723A4 (en) TREATMENT EFFECTS OF EXCESSIVE REACTIVE OXYGEN SPECIES
PT100526A (pt) Agentes quimioterapeuticos de origem vegetal com actividade antineoplastica, possuindo selectividade elevada e toxicidade bastante reduzida e processo para a sua preparacao
Priya et al. Evaluation of antioxidant activity of leaf and bark extracts of Diospyros virginiana in rats
CO5031290A1 (es) Formulacion lo
RU95105123A (ru) Средство для ухода за кожей
DE69129232D1 (de) Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen
MX9400198A (es) Acidos hidroxamicos y esteres y quelatos del mismo.
AR010343A1 (es) Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica.
AR027614A2 (es) Compuesto de purina l-nucleosido, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
GR1002955B (el) Προιοντα που προερχονται απο το φυτο κυπαρισσος και ολα τα συγγενη κωνοφορα, για χρηση στην προληψη και θεραπεια καθε τυπου υπερχοληστεριναιμιας και διαταραχης λιπιδιων, σε ανθρωπους και ζωα
MX9800126A (es) Utilizacion en una composicion de un extracto de al menos una labiada.
GR1003099B (el) Ουσιες, φυσικης ή συνθετικης προελευσης, που ανηκουν στις ομαδες των τερπενοειδων, πολυφαινολων και προανθοκυανιδων, για χρηση στην προληψη και θεραπεια καθε τυπου υπερχοληστεριναιμιας και διαταραχης λιπιδιων, σε ανθρωπους και ζωα
RU95105084A (ru) Гепатопротекторное средство природного происхождения
MD742C2 (ro) Remediu cu activitate regenerativă